Analysis of the range of medicines used for the treatment of fatty hepatosis
- Authors: Karasev M.M.1, Shevchenko T.S.2, Belousova O.V.2, Palchikov M.Y.2, Belousov E.A.2
-
Affiliations:
- Orel State University named after I.S. Turgenev
- Belgorod State National Research University
- Issue: Vol 6, No 4 (2022)
- Pages: 713-723
- Section: Medical sciences
- Published: 20.01.2026
- URL: https://ogarev-online.ru/2542-2340/article/view/369615
- ID: 369615
Cite item
Abstract
The results of the marketing analysis of the range of medicines used for the treatment of steatosis in the local pharmaceutical market are presented. The studies were carried out according to anatomical, therapeutic and chemical classification; by the number of pharmacologically active substances; chemical origin; industrial affiliation; by the number of pharmacologically active substances; segmentation of foreign manufacturing states; aggregate state; segmentation of solid dosage forms, liquid dosage forms; release from pharmacies; registration dates. Conclusions are drawn.
About the authors
Mikhail M. Karasev
Orel State University named after I.S. Turgenev
Author for correspondence.
Email: mikhailkarasev@yandex.ru
Candidate of Pharmacy, Associate Professor of Pharmacology, Clinical Pharmacology and Pharmacy Department
Russian Federation, Komsomolskaya St., 95, Orel 302026, Russian FederationTatyana S. Shevchenko
Belgorod State National Research University
Email: shevchenko_ts@bsu.edu.ru
Candidate of Biology, Associate Professor of Biochemistry Department
Russian Federation, Pobedy St., 85, Belgorod 308015, Russian FederationOlga V. Belousova
Belgorod State National Research University
Email: belousovaov31@mail.ru
Candidate of Pharmacy, Lecturer of Medical College
Russian Federation, Pobedy St., 85, Belgorod 308015, Russian FederationMikhail Y. Palchikov
Belgorod State National Research University
Email: palchikov@bsu.edu.ru
Candidate of Biology, Associate Professor of Biochemistry Department
Russian Federation, Pobedy St., 85, Belgorod 308015, Russian FederationEvgeny A. Belousov
Belgorod State National Research University
Email: belousovea@mail.ru
Candidate of Pharmacy, Associate Professor of Biochemistry Department
Russian Federation, Pobedy St., 85, Belgorod 308015, Russian FederationReferences
- Бакулин И.Г., Сандлер Ю.Г., Винницкая Е.В. и др. Сахарный диабет и неал-когольная жировая болезнь печени: грани сопряженности // Терапевтиче-ский архив. 2017. № 2. С. 59-65. https://doi.org/10.17116/terarkh201789259-65, https://elibrary.ru/xxzgex
- Лазебник Л.Б., Радченко В.Г., Голованова Е.В. и др. Неалкогольная жировая болезнь печени: клиника, диагностика, лечение // Экспериментальная и клиническая гастроэнтерология. М., 2015. № 7. С. 85-96. https://elibrary.ru/uhkffr
- Селиверстов П.В., Радченко В.Г. Роль митохондриальной цитопатии при стеатозе у больных неалкогольной жировой болезнью печени // Эффектив-ная фармакотерапия. М.: Медфорум, 2017. № 16. С. 16-24. https://elibrary.ru/ymhfmt
- Белоусова О.В., Белоусов Е.А., Петухова Е.П., Бондарев К.В., Карасев М.М. Исследование ассортимента лекарственных средств, применяемых для ле-чения язвенной болезни желудочно-кишечного тракта // Медицинское образование сегодня. 2019. № 4 (8). С. 91-98.
Supplementary files
